Eustace, A., Mani, N., Span, P., Irlam, J., Taylor, J., Betts, G., . . . West, C. (2013). A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.
Citação do estilo Chicago (17ª ed.)Eustace, A., et al. A 26-gene Hypoxia Signature Predicts Benefit from Hypoxia-modifying Therapy in Laryngeal Cancer but Not Bladder Cancer. 2013.
Citação MLA (9ª ed.)Eustace, A., et al. A 26-gene Hypoxia Signature Predicts Benefit from Hypoxia-modifying Therapy in Laryngeal Cancer but Not Bladder Cancer. 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.